Literature DB >> 19730437

Complement regulators and inhibitory proteins.

Peter F Zipfel1, Christine Skerka.   

Abstract

The complement system is important for cellular integrity and tissue homeostasis. Complement activation mediates the removal of microorganisms and the clearance of modified self cells, such as apoptotic cells. Complement regulators control the spontaneously activated complement cascade and any disturbances in this delicate balance can result in damage to tissues and in autoimmune disease. Therefore, insights into the mechanisms of complement regulation are crucial for understanding disease pathology and for enabling the development of diagnostic tools and therapies for complement-associated diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19730437     DOI: 10.1038/nri2620

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  113 in total

1.  Microbial subversion of the immune response.

Authors:  P J Lachmann
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-19       Impact factor: 11.205

Review 2.  Role of complement and complement regulators in the removal of apoptotic cells.

Authors:  L A Trouw; A M Blom; P Gasque
Journal:  Mol Immunol       Date:  2007-10-24       Impact factor: 4.407

Review 3.  Complement evasion by human pathogens.

Authors:  John D Lambris; Daniel Ricklin; Brian V Geisbrecht
Journal:  Nat Rev Microbiol       Date:  2008-02       Impact factor: 60.633

4.  A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration.

Authors:  Anne E Hughes; Nick Orr; Hossein Esfandiary; Martha Diaz-Torres; Timothy Goodship; Usha Chakravarthy
Journal:  Nat Genet       Date:  2006-09-24       Impact factor: 38.330

Review 5.  The role of CR2 in autoimmunity.

Authors:  Andrea Isaák; József Prechl; János Gergely; Anna Erdei
Journal:  Autoimmunity       Date:  2006-08       Impact factor: 2.815

6.  Platelet-activating factor and kinin-dependent vascular leakage as a novel functional activity of the soluble terminal complement complex.

Authors:  Fleur Bossi; Fabio Fischetti; Valentina Pellis; Roberta Bulla; Elisabetta Ferrero; Tom Eirik Mollnes; Domenico Regoli; Francesco Tedesco
Journal:  J Immunol       Date:  2004-12-01       Impact factor: 5.422

7.  C7 is expressed on endothelial cells as a trap for the assembling terminal complement complex and may exert anti-inflammatory function.

Authors:  Fleur Bossi; Lucia Rizzi; Roberta Bulla; Alessandra Debeus; Claudio Tripodo; Paola Picotti; Elena Betto; Paolo Macor; Carlo Pucillo; Reinhard Würzner; Francesco Tedesco
Journal:  Blood       Date:  2009-01-29       Impact factor: 22.113

Review 8.  Properdin and complement activation: a fresh perspective.

Authors:  Dennis E Hourcade
Journal:  Curr Drug Targets       Date:  2008-02       Impact factor: 3.465

9.  Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation.

Authors:  Stefan Heinen; Andrea Hartmann; Nadine Lauer; Ulrike Wiehl; Hans-Martin Dahse; Sylvia Schirmer; Katharina Gropp; Tina Enghardt; Reinhard Wallich; Steffi Hälbich; Michael Mihlan; Ursula Schlötzer-Schrehardt; Peter F Zipfel; Christine Skerka
Journal:  Blood       Date:  2009-06-15       Impact factor: 22.113

10.  Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates.

Authors:  Muriel C Schneider; Beverly E Prosser; Joseph J E Caesar; Elisabeth Kugelberg; Su Li; Qian Zhang; Sadik Quoraishi; Janet E Lovett; Janet E Deane; Robert B Sim; Pietro Roversi; Steven Johnson; Christoph M Tang; Susan M Lea
Journal:  Nature       Date:  2009-02-18       Impact factor: 49.962

View more
  469 in total

Review 1.  Carbohydrate-based cancer vaccines: target cancer with sugar bullets.

Authors:  Chang-Cheng Liu; Xin-Shan Ye
Journal:  Glycoconj J       Date:  2012-06-06       Impact factor: 2.916

Review 2.  Dynamic control of the complement system by modulated expression of regulatory proteins.

Authors:  Joshua M Thurman; Brandon Renner
Journal:  Lab Invest       Date:  2010-10-04       Impact factor: 5.662

3.  Crystallization of the factor H-binding protein, FhbB, from the periopathogen Treponema denticola.

Authors:  Daniel P Miller; John V McDowell; Jessica K Bell; Richard T Marconi
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-05-25

Review 4.  Complement dysregulation in AMD: RPE-Bruch's membrane-choroid.

Authors:  Janet R Sparrow; Keiko Ueda; Jilin Zhou
Journal:  Mol Aspects Med       Date:  2012-04-05

5.  Plasminogen is a complement inhibitor.

Authors:  Diana Barthel; Susann Schindler; Peter F Zipfel
Journal:  J Biol Chem       Date:  2012-03-27       Impact factor: 5.157

Review 6.  Aquaporin 4 and neuromyelitis optica.

Authors:  Marios C Papadopoulos; A S Verkman
Journal:  Lancet Neurol       Date:  2012-05-16       Impact factor: 44.182

Review 7.  Bacterial outer membrane vesicles in disease and preventive medicine.

Authors:  Can M Unal; Viveka Schaar; Kristian Riesbeck
Journal:  Semin Immunopathol       Date:  2010-12-12       Impact factor: 9.623

8.  High-density lipoproteins are a potential therapeutic target for age-related macular degeneration.

Authors:  Una L Kelly; Daniel Grigsby; Martha A Cady; Michael Landowski; Nikolai P Skiba; Jian Liu; Alan T Remaley; Mikael Klingeborn; Catherine Bowes Rickman
Journal:  J Biol Chem       Date:  2020-07-31       Impact factor: 5.157

Review 9.  Shiga toxin triggers endothelial and podocyte injury: the role of complement activation.

Authors:  Carlamaria Zoja; Simona Buelli; Marina Morigi
Journal:  Pediatr Nephrol       Date:  2017-12-06       Impact factor: 3.714

10.  Leucocyte complement receptor 1 (CR1/CD35) transcript and its correlation with the clinical disease activity in rheumatoid arthritis patients.

Authors:  D Anand; U Kumar; M Kanjilal; S Kaur; N Das
Journal:  Clin Exp Immunol       Date:  2014-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.